COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT ID: NCT04659759
Last Updated: 2025-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
105 participants
OBSERVATIONAL
2020-11-17
2025-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID Booster in Pregnancy and Lactation
NCT05543993
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
NCT04568044
Assessment of Alterations in Immune Function During Pregnancy and Post Parturition
NCT01200979
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 Positive
Patients diagnosed with COVID-19 during pregnancy or while breastfeeding
COVID-19 exposure
COVID-19 exposure during pregnancy
COVID-19 vaccine
Patients who receive COVID-19 vaccine during pregnancy or while breastfeeding
COVID-19 vaccine
Receipt of any COVID-19 vaccine
Controls
Reproductive age women exposed to COVID-19 vaccine
No interventions assigned to this group
Pregnant Control
Pregnant women who delivered at TJUH, COVID negative
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID-19 exposure
COVID-19 exposure during pregnancy
COVID-19 vaccine
Receipt of any COVID-19 vaccine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned delivery at Thomas Jefferson University Hospital
Exclusion Criteria
* In active labor/pain/otherwise unable to provide consent
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nemours
UNKNOWN
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20F.1043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.